12 The patients all had a very specific sub-type of cancer that was susceptible to this treatment. The sub-type makes up 5%-10% of all rectal cancers.
True, but the good news the dose only costs 11,000 dollars every three weeks.
It’s also approved for endometrial cancer in women with the same dna repair defect.
The thing is, if they can create an antibody cure for one specific type of cancer, they can and will create them for other types of cancer.
And the price will come down as the technology spreads and develops and the patents expire.